CA
NZ
UK
AU
IND
US
ARCH Venture Partners and affiliated entities filed Amendment No. 8 to their Schedule 13D with the SEC on November 6, 2026, disclosing share sales in Vir Biotechnology, Inc. common stock between November 3 and November 5, 2026.
Morgan Stanley and Parametric Portfolio Associates LLC filed Amendment No. 3 to a Schedule 13G on November 6, 2026, disclosing their beneficial ownership of Common Shares of Beneficial Interest in Western Asset Inflation-Linked Opportunities & Income Fund as of September 30, 2026.
Skyworks Solutions, Inc. SVP of Human Resources Karilee A. Durham filed a Form 4 on November 6, 2026, disclosing multiple transactions in common stock and restricted stock units on November 5, 2026, including the issuance of shares under a performance share award.
AJB Investment Fund II, LP, along with related reporting persons AJB Capital, LLC, Adam James Bradley, and Melinda Hodges Bradley, filed a Form 4 with the SEC on November 6, 2026, disclosing open-market purchases of Jewett Cameron Trading Co Ltd (NASDAQ:JCTC) common shares on …
Gregory Scott Patton, Chief Executive Officer and Director of Prairie Operating Co., filed a Form 4 on November 6, 2026, reporting a November 4, 2026 disposition of 14,583 shares of common stock withheld to satisfy tax obligations upon restricted stock vesting.
Joseph Frank Oldakowski, Chief Accounting Officer of Clover Health Investments, Corp. /DE (NASDAQ:CLOV), filed a Form 4 on November 6, 2026, disclosing the acquisition of 186,403 shares of Class A common stock through a restricted stock unit award dated November 4, 2026.
Mark Zuckerberg, Chairman, CEO, and a greater-than-10% owner of Meta Platforms, Inc., filed a statement of changes in beneficial ownership on November 6, 2026, disclosing a derivative security transaction dated November 4, 2026, involving the conversion of Class B Common Stock into Class A …
OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC filed a Schedule 13D with the SEC on November 6, 2026, disclosing beneficial ownership of 3,589,132 shares of Aspen Neuroscience, Inc. common stock following the company's initial public offering, with the triggering event dated November …
Executive Chairman Richard D. Kinder filed a Form 4 with the SEC on November 6, 2026, disclosing a purchase of 500,000 shares of Kinder Morgan, Inc. Class P Common Stock at a weighted average price of $29.9884 per share.
Harraden Circle Investments, LLC and Frederick V. Fortmiller, Jr. filed an amended beneficial ownership statement with the SEC on November 6, 2026, disclosing a combined 13.89% stake in Calisa Acquisition Corp's Ordinary Shares as of October 31, 2026.
Please wait processing your request...